Brief: Surgical Innovations Says Continues To Trade Profitably At AdjEbitda Level
18/04/2024 07:36
April 18 (Reuters) - Surgical Innovations Group PLC
SUNU.L :
* GROUP CONTINUES TO TRADE PROFITABLY AT ADJUSTED EBITDA
LEVEL
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Surgical Innovations
See all newsBrief: Surgical Innovations Says Trading In The First Half Of The Year Was Broadly Flat
UK's Surgical Innovations H1 revenue flat, EBITDA drops on Europe and US headwinds
Brief: Surgical Innovations H1 Revenue GBP 6.019 Million
Surgical Innovations - Half-year Report
Brief: Surgical Innovations Group's CEO David Marsh To Step Down